Profile data is unavailable for this security.
About the company
Fusen Pharmaceutical Co Ltd is a company mainly engaged in the cultivation of Chinese herbal medicine, pharmaceutical research and development, and sales. The Company's main business is the sales of Shuanghuanglian Oral Solutions, Shuanghuanglian Injections and other pharmaceutical products. The Company is also engaged in the research, production, and sales of various proprietary Chinese medicine and western medicine products for treating cold, fever, cardiovascular diseases and anemia. The Company mainly conducts business in the domestic market.
- Revenue in HKD (TTM)464.65m
- Net income in HKD-97.93m
- Incorporated2013
- Employees1.14k
- LocationFusen Pharmaceutical Co LtdUrban Industrial Zone, Xichuan CountyNANYANG ChinaCHN
- Websitehttps://www.fusenpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uni-Bio Science Group Ltd | 508.40m | 98.86m | 406.80m | 458.00 | 4.16 | 1.30 | 3.42 | 0.8002 | 0.0159 | 0.0159 | 0.0812 | 0.0507 | 1.27 | 2.23 | 12.21 | 1,249,140.00 | 24.76 | 1.46 | 32.97 | 1.97 | 83.51 | 80.59 | 19.44 | 1.23 | 2.17 | 168.55 | 0.2267 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
| Tianda Pharmaceuticals Ltd | 384.68m | -47.26m | 408.51m | 695.00 | -- | 0.7502 | -- | 1.06 | -0.022 | -0.022 | 0.1789 | 0.2533 | 0.4341 | 2.97 | 4.46 | 445,745.10 | -5.34 | -- | -7.97 | -- | 45.83 | -- | -12.30 | -- | 0.6748 | -9.51 | 0.1536 | -- | -- | -- | -- | -- | -- | -- |
| Transcenta Holding Ltd | 24.38m | -391.65m | 439.13m | 200.00 | -- | 0.4148 | -- | 18.01 | -0.9645 | -0.9645 | 0.0601 | 2.43 | 0.0131 | 0.8106 | 0.5768 | 113,414.40 | -21.08 | -- | -29.77 | -- | 26.02 | -- | -1,606.19 | -- | 1.04 | -31.65 | 0.2826 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| 3D Medicines Inc | 533.81m | -491.11m | 593.88m | 193.00 | -- | 0.6414 | -- | 1.11 | -2.09 | -2.09 | 2.24 | 3.59 | 0.3746 | 4.94 | 5.79 | 2,695,996.00 | -37.27 | -- | -50.88 | -- | 91.97 | -- | -99.50 | -- | 2.56 | -- | 0.2517 | -- | 11.91 | -- | 48.78 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 464.65m | -97.93m | 702.34m | 1.14k | -- | 1.25 | -- | 1.51 | -0.1313 | -0.1313 | 0.6238 | 0.7579 | 0.3212 | 1.68 | 5.01 | 404,750.90 | -6.77 | 0.9678 | -13.96 | 1.74 | 53.18 | 51.95 | -21.08 | 2.59 | 0.526 | -2.10 | 0.4031 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Lee's Pharmaceutical Holdings Ltd | 1.20bn | 63.06m | 736.04m | 993.00 | 11.67 | 0.4295 | 3.75 | 0.6139 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.58 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Zhaoke Ophthalmology Ltd | 62.48m | -247.96m | 770.06m | 297.00 | -- | 0.3468 | -- | 12.32 | -0.4552 | -0.4552 | 0.1146 | 4.07 | 0.0233 | 1.25 | 16.09 | 199,619.50 | -9.23 | -- | -10.51 | -- | 82.03 | -- | -396.86 | -- | 5.48 | -24.02 | 0.1114 | -- | -- | -- | 5.47 | -- | -- | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.23bn | 121.56m | 777.24m | 2.74k | 6.27 | 0.6431 | 3.31 | 0.3482 | 0.1435 | 0.1435 | 2.64 | 1.40 | 1.09 | 2.68 | 7.39 | 844,504.40 | 5.99 | 7.69 | 9.17 | 11.75 | 57.55 | 60.44 | 5.49 | 6.73 | 0.9033 | 213.59 | 0.1516 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | -- |
| Pak Fah Yeow International Ltd | 265.21m | 96.45m | 782.22m | 101.00 | 8.11 | 1.04 | 7.54 | 2.95 | 0.3094 | 0.3094 | 0.8507 | 2.41 | 0.2869 | 2.84 | 23.53 | 2,600,118.00 | 10.44 | 3.99 | 11.32 | 4.18 | 87.05 | 80.79 | 36.37 | 21.27 | 4.22 | 5.26 | 0.0055 | 100.68 | 76.06 | 12.94 | 250.66 | 23.02 | 18.83 | -8.06 |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 916.22m | 187.44m | 812.36m | 678.00 | 4.33 | 0.4694 | 6.46 | 0.8866 | 0.3346 | 0.3346 | 1.64 | 3.09 | 0.3574 | 2.10 | 2.94 | 1,080,449.00 | 7.31 | 7.67 | 10.25 | 10.48 | 75.46 | 78.79 | 20.46 | 20.68 | 1.62 | -- | 0.0502 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| Hbm Holdings Ltd | 561.26m | 165.56m | 920.28m | 158.00 | 5.33 | 0.9231 | 4.70 | 1.64 | 0.225 | 0.225 | 0.7613 | 1.30 | 0.3258 | 3.96 | 16.67 | 3,170,948.00 | 9.59 | -54.61 | 13.25 | -66.04 | 95.57 | 97.81 | 29.42 | -400.28 | 3.44 | 8.14 | 0.3502 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jbm (Healthcare) Ltd | 648.42m | 130.46m | 961.74m | 279.00 | 7.91 | 1.00 | 5.23 | 1.48 | 0.1479 | 0.1479 | 0.7338 | 1.17 | 0.4645 | 4.25 | 5.98 | 2,324,068.00 | 9.83 | 4.38 | 12.04 | 5.52 | 52.14 | 46.47 | 21.16 | 12.69 | 1.25 | 89.68 | 0.1155 | 32.98 | 24.62 | 16.09 | 128.51 | 19.99 | 2.26 | -- |
Data as of Oct 30 2024. Currency figures normalised to Fusen Pharmaceutical Co Ltd's reporting currency: Hong Kong Dollar HKD
0.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 31 Jul 2024 | 259.00k | 0.04% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 14.42k | 0.00% |
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
